Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis. https://t.co/dhGDUsyQFI
“Remdesivir inhibited Ituri Ebola virus at a 50% effective concentration (EC50) of 12nM“ https://t.co/gjjdb6EgJW https://t.co/T7yONxVz2f
@JTSglobalhealth @OutbreakJake @NIHRresearch @lid Patient self-administration of amiodarone reported here https://t.co/i0egIoFos9, mentioned briefly by @OutbreakJake here https://t.co/jrgE7KsLO4 & here https://t.co/7qoDaLoPrO, & in vitro inhibition
Synthesis of Ebola from sequence data #newtechnology https://t.co/cJmbofqSTm
Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis https://t.co/ebDO2eF5ox
RT @MSFsci: Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the DRC: a phylogenetic an…
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the DRC: a phylogenetic and in vitro analysis in @TheLancetInfDis: https://t.co/zAtmyt1DwR with comment: https://t.co/MKDrTtTZvI https://t.co/5s3uyGp1xv
@HelenBranswell Seems like they’re fighting at least two different Ebola virus strains that independently crossed over into the human population in DRC. https://t.co/9GroTaSfnR
RT @CDC_AMD: “…it’s vitally important to make sure existing treatments work against the virus that’s making people sick now.” Laura McMulla…
RT @MSFsci: Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in DRC: a phylogenetic & in v…
Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in DRC: a phylogenetic & in vitro analysis in @TheLancetInfDis: https://t.co/fQzIwMy8B7 with comment: https://t.co/XL0nYyqi0k https://t.co/7xvA4dxq0c
RT @CDC_AMD: “…it’s vitally important to make sure existing treatments work against the virus that’s making people sick now.” Laura McMulla…
“…it’s vitally important to make sure existing treatments work against the virus that’s making people sick now.” Laura McMullan, CDC microbiologist Research shows two treatments in use against the current Ebola virus outbreak in eastern DRC are effective.
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis. https://t.co/7ImefwcMOx
RT @CDC_AMD: AMD Clips: Using a reverse-genetic system to generate the Ebola-Ituri virus strain, CDC scientists show that the virus is full…
RT @CDC_AMD: AMD Clips: Using a reverse-genetic system to generate the Ebola-Ituri virus strain, CDC scientists show that the virus is full…
AMD Clips: Using a reverse-genetic system to generate the Ebola-Ituri virus strain, CDC scientists show that the virus is fully sensitive to two treatments being used in the ongoing Ebola outbreak in eastern Democratic Republic of Congo (DRC). https://t.c
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis. https://t.co/EnFdkvcE8g
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDC_AMD: “…it’s vitally important to make sure existing treatments work against the virus that’s making people sick now.” Laura McMulla…
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
RT @ISARICAR: Great work from @CDCgov in @TheLancetInfDis investigating the efficacy of existing experimental therapies against the ebola I…
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @ISARICAR: Great work from @CDCgov in @TheLancetInfDis investigating the efficacy of existing experimental therapies against the ebola I…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
#Ebola treatments! Need #Pharmaceutical #laboratories for #drugdiscovery and innovation? https://t.co/ZosE3FcAGj #medicine #infectiousdisease #vaccine
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
RT @CDCDirector: .@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective…
.@CDC_NCEZID's Dr. Inger Damon explains how work on two #Ebola investigational treatments could lead to safe and effective therapies to help cure Ebola patients. Read the full story in @TheLancetInfDis: https://t.co/huRtHMr2Sq
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDC_AMD: “…it’s vitally important to make sure existing treatments work against the virus that’s making people sick now.” Laura McMulla…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
“…it’s vitally important to make sure existing treatments work against the virus that’s making people sick now.” Laura McMullan, CDC microbiologist Research shows two treatments in use against the current Ebola virus outbreak in eastern DRC are effective.
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
Promising treatments for Ebola #CLS538
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
Article molt interessant. Em quedo amb dos apunts de #bioproteccio, lligats al #bioterrorisme o #biocrim. Si tens una seqüència genòmica #openaccess és qüestió de temps i un xic de diners tenir virus infecciosos. El segon apunt? Això ho sabem des de fa ...
Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis https://t.co/Vo0J2lUhxr
They didn’t have the correct type of Ebola to work on - so they went ahead and made it in a lab. The science behind this blows my mind. But anyway, the study produced some good news #Ebola #EVD https://t.co/PNXVwkGHiu
RT @CENDUCBerkeley: Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Rep…
Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis https://t.co/SPAXCD8kQh
RT @LubanLab: Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic…
Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis - The Lancet Infectious Diseases https://t.co/pLI2sdsZAe
RT @pathogenomenick: Virus strain reconstructed for testing from publicly available genome sequences! https://t.co/orY262uVsa
RT @monicaMedHist: This is a massive epidemiological importance: "The phylogenetic analysis of whole-genome sequences from each Ebola virus…
RT @monicaMedHist: This is a massive epidemiological importance: "The phylogenetic analysis of whole-genome sequences from each Ebola virus…
Virus strain reconstructed for testing from publicly available genome sequences!
Promising data from @CDCgov in @TheLancetInfDis shows 2 investigative treatments for #Ebola block virus growth in the lab. #FredNatLab teams are in the DRC supporting @NIAIDNews in #clinicaltrials during current outbreak.
RT @EbolaNewsViews: Characterisation of infectious #Ebola virus from the ongoing outbreak to guide response activities in the #DRCongo: a p…
Characterisation of infectious #Ebola virus from the ongoing outbreak to guide response activities in the #DRCongo: a phylogenetic and in vitro analysis @TheLancetInfDis https://t.co/u6gkocByQG https://t.co/wz0DorSYQO
RT @monicaMedHist: This is a massive epidemiological importance: "The phylogenetic analysis of whole-genome sequences from each Ebola virus…
RT @monicaMedHist: This is a massive epidemiological importance: "The phylogenetic analysis of whole-genome sequences from each Ebola virus…
RT @monicaMedHist: This is a massive epidemiological importance: "The phylogenetic analysis of whole-genome sequences from each Ebola virus…
RT @monicaMedHist: This is a massive epidemiological importance: "The phylogenetic analysis of whole-genome sequences from each Ebola virus…
#CLS538 New treatment for this deadly disease!
Gloire à Dieu!
RT @ISARICAR: Great work from @CDCgov in @TheLancetInfDis investigating the efficacy of existing experimental therapies against the ebola I…
Great work from @CDCgov in @TheLancetInfDis investigating the efficacy of existing experimental therapies against the ebola Ituri strain involving in the ongoing outbreak in DRC #ebola https://t.co/DIBKJVGIyy
RT @CDCDirector: Two #Ebola investigational treatments now being used in the ongoing #DRC outbreak are effective in @CDCgov lab studies. Th…
"...for all clades, the Bayesian analysis suggests the variants of EBOV to be circulating 1–2 years before each outbreak." #IsItTimeToRampUpSurveillenceYet (globally) https://t.co/kFxtyiLevc
This is a massive epidemiological importance: "The phylogenetic analysis of whole-genome sequences from each Ebola virus outbreak suggests there are at least two Ebola virus strains in DR Congo, which have independently crossed into the human population."
Quite an interesting read! !
Characterisation of infectious #Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the #Congo: a phylogenetic and in vitro analysis https://t.co/eufiHRpLvh